Additionally, A3C may inhibit the malignant behaviors of PCa cells through regulating key molecules involved in synergistic mechanisms: upregulating STING1 and its downstream molecules in intracellular inflammation, increasing the expression of DNA damage protection-related proteins such as GSTP1 and GPX3, and upregulating GAS1 to suppress the cell cycle. The gene discussed is GPX3; the disease is posterior cortical atrophy.